Zobrazeno 1 - 4
of 4
pro vyhledávání: '"M. C. De Santis"'
Autor:
S. Di Cosimo, C. Depretto, R. Miceli, P. Baili, S. Ljevar, M. Sant, V. Cappelletti, S. Folli, M. Gennaro, F. G. De Braud, G. Bianchi, A. Vingiani, G. Pruneri, A. Marchianò, E. La Rocca, M. C. De Santis, G. P. Scaperrotta
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 148:775-781
Autor:
E. La Rocca, M. C. De Santis, M. Silvestri, E. Ortolan, M. Valenti, S. Folli, F. G. de Braud, G. V. Bianchi, G. P. Scaperrotta, G. Apolone, M. G. Daidone, V. Cappelletti, G. Pruneri, S. Di Cosimo
Purpose Physical examinations and annual mammography (minimal follow-up) are as effective as laboratory/imaging tests (intensive follow-up) in detecting breast cancer (BC) recurrence. This statement is now challenged by the availability of new diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::112db9785d549050c733edf1a8660c8c
http://hdl.handle.net/11379/561316
http://hdl.handle.net/11379/561316
Autor:
S, Di Cosimo, C, Depretto, R, Miceli, P, Baili, S, Ljevar, M, Sant, V, Cappelletti, S, Folli, M, Gennaro, F G, De Braud, G, Bianchi, A, Vingiani, G, Pruneri, A, Marchianò, E, La Rocca, M C, De Santis, G P, Scaperrotta
Publikováno v:
Journal of cancer research and clinical oncology. 148(4)
Mammographic density (MD) is a risk factor for breast cancer (BC) development, and recurrence. However, its predictive value has been less studied. Herein, we challenged MD as a biomarker associated with response in patients treated with neoadjuvant
Autor:
G F, Baraghini, G F, Bolelli, M, Capelli, R, Motta, A, Andreotti, S, Cavicchi, C, Castellucci, T, Castrioto, M C, De Santis, F, Franceschetti
Publikováno v:
Annali dell'Istituto superiore di sanita. 31(1)
For correct enforcement of an external quality assessment (EQA) scheme, suitable parameters are required for the assessment of analytical performance. Traditional EQA schemes have always been chiefly concerned with the agreement of analytical results